Alnylam Pharmaceuticals
ALNY
#578
Rank
HK$273.35 B
Marketcap
HK$2,129
Share price
-0.48%
Change (1 day)
51.46%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

Alnylam Pharmaceuticals (ALNY) - Net assets

Net assets on the balance sheet as of June 2024 : -HK$23.91 M

According to Alnylam Pharmaceuticals 's latest financial reports the company has -HK$23.91 M in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Alnylam Pharmaceuticals - Net assets on balance sheet (from 2003 to 2024)

Net assets by year

Year Net assets Change
2023-12-31$-HK$1.73 B39.39%
2022-12-31$-HK$1.24 B-126.95%
2021-12-31$HK$4.58 B-41.79%
2020-12-31$HK$7.87 B-29.68%
2019-12-31$HK$11.20 B9.91%
2018-12-31$HK$10.19 B-26.13%
2017-12-31$HK$13.80 B93.4%
2016-12-31$HK$7.13 B-27.2%
2015-12-31$HK$9.80 B34.94%
2014-12-31$HK$7.26 B246.5%
2013-12-31$HK$2.09 B101.76%
2012-12-31$HK$1.03 B13.38%
2011-12-31$HK$0.91 B-25.56%
2010-12-31$HK$1.23 B-10.79%
2009-12-31$HK$1.38 B-11.9%
2008-12-31$HK$1.56 B0.78%
2007-12-31$HK$1.55 B-0.65%
2006-12-31$HK$1.56 B226.65%
2005-12-31$HK$0.47 B48.29%
2004-12-31$HK$0.32 B-255.78%
2003-12-31$-HK$0.21 B472.2%
2002-12-31$-HK$36.24 M

Net assets for similar companies or competitors

Company Net assets differencediff. Country
HK$2.64 B-11,152.30%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$219.86 B-919,754.39%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$8.39 B-35,218.03%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$10.87 B-45,594.62%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$0.76 B-3,301.21%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$326.62 B-1,366,321.06%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
HK$609.97 B-2,551,505.28%๐Ÿ‡ซ๐Ÿ‡ท France
HK$51.15 B-214,087.61%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel